Ultrasound Devices Market Report

Global Ultrasound Devices Market Size

The value of the global ultrasound devices market is projected to grow to USD 17.36 billion by 2034 and USD 11.14 billion in 2026, growing at a CAGR of 5.7% during the forecast period. The ultrasound devices market size was valued at USD 10.54 billion in 2025.

The ultrasound devices are diagnostic imaging systems that utilize high frequency sound waves to visualize internal body structures in real time. These devices range from large cart-based systems used in hospitals for comprehensive diagnostics to compact handheld units employed for point of care assessments. Ultrasound technology is favored for its non-invasive nature lack of ionizing radiation and cost effectiveness compared to computed tomography or magnetic resonance imaging. According to the World Health Organization, approximately 360 million medical imaging procedures are performed globally each year with ultrasound representing a significant portion due to its versatility in obstetrics cardiology and abdominal imaging. The Centers for Disease Control and Prevention states that chronic diseases, such as heart disease and cancer account for 7 out of 10 deaths in the United States driving the need for regular diagnostic monitoring where ultrasound plays a pivotal role. Furthermore, the American College of Radiology emphasizes the importance of portable ultrasound in emergency settings for rapid assessment of trauma and internal bleeding. As healthcare systems increasingly prioritize early detection and minimally invasive procedures the demand for advanced ultrasound technologies continues to rise. The integration of artificial intelligence and cloud connectivity into modern ultrasound platforms further enhances diagnostic accuracy and workflow efficiency positioning these devices as essential tools in contemporary medical practice.

MARKET DRIVERS

Rising Prevalence of Chronic Diseases and Geriatric Population

The escalating prevalence of chronic diseases coupled with a rapidly aging global population is fuelling the growth of the ultrasound devices market. Chronic conditions, such as cardiovascular diseases diabetes and cancer require frequent diagnostic monitoring to manage patient health effectively. According to the World Health Organization, non-communicable diseases kill 41 million people each year which is equivalent to 71% of all deaths globally. This substantial burden necessitates regular imaging for early detection and treatment planning. Ultrasound is particularly valuable in cardiology for assessing heart function and in oncology for tumor detection and biopsy guidance. The United Nations Department of Economic and Social Affairs projects that the number of persons aged 65 years or older worldwide is projected to more than double from 727 million in 2020 to 1.5 billion in 2050. Older adults are more susceptible to chronic conditions and require more frequent medical interventions including diagnostic imaging. The American Heart Association reports that heart disease remains the leading cause of death globally requiring extensive use of echocardiography for diagnosis and management. As the geriatric population grows, the demand for safe and repeatable imaging modalities like ultrasound increases significantly. Healthcare providers rely on ultrasound for its ability to provide real time insights without exposing patients to harmful radiation making it ideal for long term monitoring of elderly patients with multiple comorbidities.

Technological Advancements and Portability of Devices

The rapid technological advancements and the increasing portability of ultrasound devices by expanding access to diagnostic imaging in diverse clinical settings is additionally promoting the growth of the ultrasound devices market. Modern ultrasound systems are becoming smaller lighter and more powerful enabling their use in point of care environments, such as emergency rooms ambulances and remote clinics. According to the Journal of Medical Internet Research, the adoption of handheld ultrasound devices has increased by over 30% in recent years due to improvements in battery life image quality and wireless connectivity. These portable devices allow physicians to perform immediate assessments at the bedside reducing the time to diagnosis and improving patient outcomes. The integration of artificial intelligence algorithms into ultrasound software enhances image interpretation and reduces operator dependency making the technology accessible to less experienced users. The Food and Drug Administration has cleared numerous AI enabled ultrasound applications that assist in automating measurements and identifying abnormalities. Furthermore the development of wireless probes eliminates cable clutter and improves ease of use in crowded clinical spaces. Telemedicine capabilities embedded in modern ultrasound systems enable remote consultations allowing specialists to guide examinations from distant locations. This technological evolution democratizes access to high quality diagnostic imaging particularly in underserved areas where traditional large-scale equipment is unavailable.

MARKET RESTRAINTS

High Cost of Advanced Ultrasound Systems

The substantial cost associated with acquiring and maintaining advanced ultrasound systems, particularly in resource constrained healthcare settings is inhibiting the growth of the ultrasound devices market. High end ultrasound machines equipped with specialized probes and advanced software features can cost between 50000 and 150000 dollars or more depending on the configuration. Many low and middle income countries spend less than 100 dollars per capita on health annually limiting their ability to invest in expensive diagnostic equipment. For small private practices and rural clinics, these capital expenditures represent a significant financial burden that may not be immediately offset by reimbursement rates. Additionally, the ongoing costs of maintenance software updates and probe replacements add to the total cost of ownership. The Healthcare Financial Management Association notes that budget constraints often force healthcare facilities to delay equipment upgrades resulting in the use of outdated technology that may compromise diagnostic accuracy. In developing regions, the lack of adequate funding infrastructure and trained personnel further hinders the adoption of advanced ultrasound systems. While portable devices offer a lower cost alternative, they may lack the comprehensive functionality required for complex diagnoses. This financial barrier restricts the widespread deployment of state of the art ultrasound technology leaving many patients without access to optimal diagnostic care.

Shortage of Skilled Sonographers and Technicians

The global shortage of qualified sonographers and ultrasound technicians is also impeding the growth of the ultrasound devices market. Operating ultrasound equipment requires specialized training and expertise to acquire high quality images and interpret findings accurately. There is a persistent workforce gap in the United States with projections indicating a need for thousands of new sonographers to meet growing demand. This shortage leads to longer wait times for patients increased workload for existing staff and potential burnout. In many developing countries, the situation is even more crucial with fewer than one radiologist per 100000 people, as reported by the study. Without skilled operators even the most advanced ultrasound devices cannot deliver accurate diagnostic results. Training programs are often lengthy and expensive creating a hurdle in workforce development. Additionally, the complexity of new technologies, such as three dimensional imaging and elastography requires continuous professional development, which may not be readily available in all regions. The reliance on highly skilled personnel limits the scalability of ultrasound services particularly in primary care settings where general practitioners may lack specific training.

MARKET OPPORTUNITIES

Expansion into Point of Care and Home Healthcare Settings

The expansion of ultrasound technology into point of care and home healthcare settings by decentralizing diagnostic services is to set up new opportunities for the growth of the ultrasound devices market. Traditionally confined to hospital radiology departments ultrasound devices are now being integrated into emergency medicine primary care and even home monitoring scenarios. The point of care ultrasound improves diagnostic accuracy and reduces the need for additional testing leading to cost savings and faster treatment decisions. The rise of telehealth services further supports this trend by enabling remote guidance for ultrasound examinations performed by nurses or paramedics in the field. The Centers for Medicare and Medicaid Services has expanded reimbursement policies for certain point of care ultrasound procedures encouraging wider adoption among healthcare providers. Portable and handheld devices are particularly well suited for home healthcare allowing patients with chronic conditions to receive regular monitoring without frequent hospital visits. This shift aligns with the broader industry move towards value-based care and patient centered models. Manufacturers can capitalize on this opportunity by developing user friendly devices with intuitive interfaces and automated features that empower non specialist users. Partnerships with home health agencies and insurance providers can facilitate the integration of ultrasound into routine care plans.

Integration of Artificial Intelligence and Automation

The integration of artificial intelligence and automation into ultrasound devices to enhance diagnostic efficiency and accessibility is additionally to promote new opportunities for the growth of the ultrasound devices market. AI algorithms can assist in image acquisition optimization automatic measurement and anomaly detection reducing the cognitive load on sonographers and minimizing inter observer variability. The journal AI assisted ultrasound has demonstrated comparable accuracy to expert radiologists in detecting certain conditions, such as thyroid nodules and breast lesions. This technology enables less experienced users to perform reliable examinations thereby addressing the shortage of skilled personnel. Automated workflows streamline the documentation process reducing administrative burden and allowing clinicians to spend more time with patients. The Food and Drug Administration has approved several AI powered ultrasound tools that provide real time feedback during scans ensuring optimal image quality. Furthermore, AI can analyze large datasets to identify patterns and predict disease progression supporting personalized medicine initiatives. Cloud based platforms facilitate the sharing of AI models and updates across devices ensuring consistent performance improvements. Manufacturers who embed robust AI capabilities into their systems can differentiate their products and offer value added services such as predictive analytics and decision support. As machine learning models become more sophisticated, the potential for ultrasound to serve as a primary screening tool in various medical specialties expands opening new revenue streams and improving overall healthcare delivery.

MARKET CHALLENGES

Regulatory Hurdles and Reimbursement Complexities

The complex regulations and varying reimbursement policies is certainly a major challenge for the growth of the ultrasound devices market. Each country has its own set of regulations for medical device approval, which can be time consuming and costly to comply with. The new Medical Device Regulation in Europe has introduced stricter requirements for clinical evidence and post market surveillance increasing the burden on manufacturers. In the United States, the Food and Drug Administration requires rigorous premarket approval for new ultrasound technologies particularly those involving artificial intelligence. Additionally, reimbursement policies vary widely across regions and payers affecting the financial viability of adopting new ultrasound systems. The American Medical Association notes that inconsistent coding and payment structures for point of care ultrasound create uncertainty for healthcare providers. In many developing countries, the lack of clear regulatory frameworks and reimbursement mechanisms hinders market entry for international vendors. Manufacturers must invest heavily in regulatory affairs and health economics teams to navigate these complexities. Delays in approval or unfavorable reimbursement decisions can significantly impact product launch timelines and return on investment.

Image Quality Limitations in Obese Patients

Achieving high quality images in obese patients is limiting their diagnostic utility in certain populations. The image quality limitations in obese patients is also to decline the growth of the ultrasound devices market. Sound waves attenuate significantly as they pass through adipose tissue resulting in reduced penetration and poorer image resolution. According to the survey, the global prevalence of obesity has nearly tripled since 1975 with over 650 million adults classified as obese in 2016. This demographic trend presents a growing challenge for ultrasound diagnostics, as standard probes may struggle to visualize deep structures adequately. While lower frequency probes offer better penetration, they often sacrifice resolution making it difficult to detect small abnormalities. Manufacturers are developing specialized transducers and beamforming techniques to improve image quality in difficult to scan patients but these solutions often come at a higher cost. The American Journal of Roentgenology, suboptimal image quality can lead to inconclusive diagnoses requiring follow up tests with other modalities such as computed tomography or magnetic resonance imaging. This not only increases healthcare costs but also exposes patients to additional risks, such as radiation or contrast agents.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Technology Insights

The diagnostic ultrasound segment held a significant share of the ultrasound devices market in 2025 due to its widespread application in routine clinical examinations across various medical specialties, including obstetrics gynecology cardiology and abdominal imaging. The non-invasive nature of diagnostic ultrasound, which avoids ionizing radiation making it safe for repeated use, particularly in vulnerable populations, such as pregnant women and children. According to the American College of Radiology, over 38 million ultrasound procedures are performed annually in the United States alone reflecting its status as a first line diagnostic tool. The versatility of diagnostic ultrasound allows for real time visualization of soft tissues blood flow and organ function, which is crucial for early disease detection. The World Health Organization emphasizes that accessible diagnostic imaging is essential for managing maternal and child health globally further driving demand in developing regions. Additionally, the relatively lower cost of diagnostic ultrasound compared to magnetic resonance imaging or computed tomography makes it economically viable for healthcare providers with limited budgets. Technological advancements, such as high-resolution probes and three-dimensional imaging have enhanced diagnostic accuracy reinforcing its clinical utility. The integration of diagnostic ultrasound into standard care protocols for chronic disease management ensures consistent demand. As healthcare systems prioritize preventive care and early intervention, diagnostic ultrasound remains the cornerstone of modern medical imaging infrastructure supporting a vast array of clinical decisions and patient monitoring activities worldwide.

The therapeutic ultrasound segment is expected to witness a fastest CAGR of 8.5% from 2026 to 2034 owing to its expanding applications in physical therapy pain management and focused ultrasound surgery. The increasing prevalence of musculoskeletal disorders and the shift towards non-invasive treatment options that reduce recovery time and complications associated with traditional surgery is likely to boost the growth of the segment. According to the research, approximately 27% of adults in the United States report having some form of arthritis which is a leading cause of disability and drives demand for therapeutic interventions like ultrasound therapy. High intensity focused ultrasound is gaining traction in oncology for tumor ablation offering a precise alternative to surgical resection. The National Institutes of Health supports research into therapeutic ultrasound for neurological conditions, such as essential tremor and Parkinson’s disease broadening its clinical scope. Furthermore, the rise in sports injuries and an aging population seeking conservative pain management solutions contributes to market expansion. Technological innovations such as image guided focused ultrasound allow for targeted tissue destruction without incisions enhancing patient safety and outcomes. The efficacy of therapeutic ultrasound accumulates insurance coverage and physician adoption increase accelerating market growth.

By Device Display Insights

The color display segment was the largest by holding 40.2% of the ultrasound devices market share in 2025 due to their superior ability to visualize blood flow and tissue differentiation. The clinical necessity of Doppler imaging, which uses color coding to represent the direction and velocity of blood flow providing vital hemodynamic information. The cardiovascular diseases remain the leading cause of death globally necessitating detailed vascular assessments that only color Doppler can provide effectively. Color displays enhance the contrast between different tissue types allowing physicians to identify abnormalities, such as tumors cysts or inflammation with greater precision than black and white systems. The Society of Radiologists in Ultrasound recommends the use of color flow imaging for evaluating thyroid nodules and liver lesions underscoring its importance in standard diagnostic protocols. Additionally, modern color displays offer higher resolution and brightness improving visibility in well-lit clinical environments. The integration of advanced image processing algorithms enhances color fidelity and reduces artifacts ensuring reliable interpretation. As healthcare standards rise, the expectation for comprehensive diagnostic information drives the preference for color display systems in hospitals and diagnostic centers. The ability to capture and store color images for electronic health records, further supports their adoption facilitating better communication among healthcare providers and improving continuity of care for patients with complex conditions.

The black and white display segment is expected to register a fastest CAGR of 6.2% during the forecast period owing to the demand for cost effective and durable devices for basic screening and guidance procedures, where color flow information is not strictly necessary. The improving access to basic diagnostic tools in low income countries is a priority and black and white portable units offer an affordable solution for primary health centers. These devices are widely used for guiding needle biopsies assessing bladder volume and performing rapid trauma assessments in emergency settings, where speed and simplicity are paramount. The rugged design and lower power consumption of black and white units make them ideal for remote clinics and mobile health units with limited infrastructure. Advances in grayscale imaging technology have significantly improved the clarity and detail of black and white images narrowing the gap with color systems for certain applications. , the lower maintenance costs and ease of use appeal to non-specialist healthcare workers, such as nurses and paramedics, who require quick and reliable diagnostic support.

By Portability Insights

The trolley or cart based segment was the largest by accounting for 33.3% of the ultrasound devices market share in 2025 due to their comprehensive functionality superior image quality and extensive feature sets required for complex diagnostic procedures in hospitals and large diagnostic centers. The primary driver for this dominance is the need for high performance imaging in specialized departments, such as radiology cardiology and obstetrics where detailed anatomical visualization is critical. The large hospital systems account for the majority of advanced diagnostic imaging volumes requiring robust systems with multiple probe options and advanced software capabilities. Cart based systems typically support high end features, such as three dimensional, four dimensional, and elastography imaging, which are essential for accurate diagnosis of complex conditions. They also offer larger screens and ergonomic designs that reduce operator fatigue during lengthy examinations. The integration of these systems with hospital information networks facilitates seamless data management and reporting. Furthermore, teaching hospitals and academic medical centers prefer cart based systems for their educational value and ability to handle diverse clinical cases.

The compact and handheld segment is esteemed to register a fastest CAGR of 12.4% from 2026 to 2034 with the trend towards point of care diagnostics and decentralized healthcare delivery. The miniaturization of technology, which has enabled the development of pocket sized devices that connect to smartphones or tablets offering high quality imaging at a fraction of the cost of traditional systems. The adoption of handheld ultrasound by primary care physicians has increased significantly as it allows for immediate bedside assessment reducing referral delays and improving patient throughput. These devices are particularly valuable in emergency medicine rural health and home care settings, where portability and ease of use are essential. The lower price point makes them accessible to smaller clinics and individual practitioners, who cannot afford large cart-based systems. Additionally, the integration of wireless connectivity and cloud storage enables remote consultation and data sharing enhancing collaborative care. Regulatory approvals for handheld devices have expanded their clinical indications further boosting confidence among users.

REGIONAL ANALYSIS

North America Ultrasound Devices Market Analysis

North America

North America was the largest contributor of the global ultrasound devices market by capturing 38.1% of the advanced healthcare infrastructure, high adoption of innovative technologies, and substantial healthcare expenditure. The region benefits from a well established network of hospitals and diagnostic centers that prioritize early detection and minimally invasive procedures. The presence of major ultrasound manufacturers in the region fosters continuous innovation and competition leading to the development of cutting edge features such as artificial intelligence and portable devices. Strict regulatory standards enforced by the Food and Drug Administration ensure high quality and safety of medical devices encouraging trust among healthcare providers. Additionally, the high prevalence of chronic diseases such as cancer and cardiovascular conditions drives consistent demand for diagnostic imaging. The adoption of point of care ultrasound in emergency departments and primary care settings is widespread supported by favorable reimbursement policies.

Europe Ultrasound Devices Market Analysis

Europe ultrasound devices market growth is strictly growing at fastest CAGR with the universal healthcare systems government initiatives for digital health and strict regulatory frameworks. The European Union’s Medical Device Regulation imposes rigorous requirements for clinical evidence and post market surveillance ensuring high standards for ultrasound equipment. Countries, such as Germany, France, and the United Kingdom have well developed healthcare infrastructures with high levels of ultrasound utilization in obstetrics, cardiology, and musculoskeletal imaging. The aging population in Europe increases the demand for diagnostic services driving the need for efficient and accurate imaging solutions. Furthermore, the emphasis on cost containment in public healthcare systems favors the adoption of portable and cost effective ultrasound devices that can be shared across departments. Government funding for research and development supports innovation in therapeutic ultrasound and AI integration. The presence of renowned medical research institutions also drives demand for specialized high-end systems.

Asia-Pacific Ultrasound Devices Market Analysis

The Asia-Pacific ultrasound devices market growth is likely to grow with the rapid healthcare infrastructure development, increasing healthcare expenditure, and rising awareness of diagnostic services. Countries, such as China, India, Japan, and Australia are witnessing significant investments in hospital construction and laboratory modernization. The healthcare expenditure in Asia has been growing steadily, as governments prioritize improving access to quality healthcare services. The large population base and increasing prevalence of infectious and chronic diseases drive high demand for diagnostic testing necessitating efficient and affordable ultrasound solutions. India is seeing a boom in private diagnostic chains that are adopting advanced ultrasound systems to cater to a growing middle class. Japan’s advanced technological landscape supports the adoption of high end ultrasound with automation and artificial intelligence features. Additionally, medical tourism in countries like Thailand and Singapore drives demand for internationally accredited facilities equipped with state of the art imaging technology.

Latin America Ultrasound Devices Market Analysis

Latin America ultrasound devices market growth is driven by healthcare reforms, increasing private insurance coverage, and urbanization. Brazil, Mexico, and Argentina are the largest contributors in the region with ongoing efforts to modernize public and private healthcare facilities. Improving diagnostic capacity is a priority for many Latin American countries to address the burden of communicable and non-communicable diseases. The expansion of private hospital chains and diagnostic centers is driving the adoption of ultrasound to enhance operational efficiency and patient service quality. However economic volatility and budget constraints in the public sector limit the pace of technology adoption compared to North America and Europe. The international collaborations and foreign investments in healthcare infrastructure are facilitating the introduction of advanced ultrasound solutions. The growing awareness of preventive healthcare among the middle class is increasing the volume of outpatient diagnostic tests creating demand for scalable and user-friendly systems. Portable ultrasound devices are gaining traction due to their lower cost and ease of deployment in remote areas.

Middle East and Africa Ultrasound Devices Market Analysis

The Middle East and Africa ultrasound devices market growth is likely to grow with the government investments in healthcare infrastructure and the expansion of medical tourism. Countries in the Gulf Cooperation Council, such as Saudi Arabia and the United Arab Emirates are heavily investing in smart healthcare initiatives as part of their economic diversification strategies. The growing health systems and access to essential services is a key goal for many African nations leading to increased demand for basic and portable ultrasound tools. The African country is characterized by a mix of modern private facilities in urban centers and under resourced public clinics in rural areas. International aid and non governmental organizations are supporting the deployment of digital health solutions including handheld ultrasound to improve disease surveillance and maternal health outcomes. Mobile health technologies and battery operated devices are particularly relevant in Africa due to limited fixed infrastructure

COMPETITIVE LANDSCAPE

The competition in the ultrasound devices market is intense and characterized by the presence of established multinational corporations and specialized regional manufacturers who compete on technology quality and cost efficiency. Major players leverage their extensive research and development capabilities to innovate in artificial intelligence cloud connectivity and miniaturization creating smarter and more portable imaging solutions. Price competition remains significant particularly in the portable and handheld segments, where numerous entrants offer affordable alternatives to traditional systems. However, differentiation through superior image resolution ergonomic design and comprehensive service support helps premium suppliers maintain higher margins. The shift towards point of care diagnostics has intensified competition as companies race to provide user friendly devices that empower non-specialist clinicians. Regulatory compliance across different regions adds complexity requiring companies to maintain flexible and adaptable product portfolios. Supply chain resilience for electronic components has become a key competitive advantage as disruptions can significantly impact production schedules.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the global ultrasound devices market include

• General Electric Company (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Toshiba Corporation (Japan)
• Siemens AG (Germany)
• Hitachi Ltd. (Japan)
• Samsung Electronics Co., Ltd. (South Korea)
• FUJIFILM Holdings Corporation (Japan)
• Esaote S.p.A. (Italy)
• Mindray Medical International Ltd. (China)
• Analogic Corporation (U.S.)

Top Players in the Global Ultrasound Devices Market

GE HealthCare Technologies Inc

GE HealthCare Technologies Inc is a global leader in medical imaging providing a comprehensive portfolio of ultrasound systems ranging from high end cart based units to portable handheld devices. The company strengthens its market position through continuous innovation in artificial intelligence and cloud connectivity, which enhance diagnostic accuracy and workflow efficiency. Recent actions include the launch of advanced software solutions that automate image optimization and measurement tasks reducing operator dependency. GE HealthCare also focuses on expanding its presence in point of care settings by developing rugged and user-friendly handheld probes. The company collaborates with healthcare providers to integrate ultrasound data into electronic health records ensuring seamless information exchange.

Koninklijke Philips NV

Koninklijke Philips NV is a prominent player in the ultrasound devices market known for its high-quality imaging systems and strong focus on women’s health and cardiology applications. The company offers a wide range of ultrasound platforms equipped with advanced transducer technology and intelligent workflow tools. Philips strengthens its position by investing in research and development to create specialized solutions for emerging countries and remote care settings. Recent initiatives, include the expansion of its Lumify mobile ultrasound ecosystem, which allows clinicians to perform examinations using smart devices. The company also emphasizes interoperability by integrating its ultrasound systems with broader healthcare IT infrastructure. Philips actively engages in strategic partnerships to enhance its artificial intelligence capabilities and provide predictive analytics.

Siemens Healthineers AG

Siemens Healthineers AG is a key contributor to the ultrasound devices market offering robust and versatile imaging systems designed for various clinical specialties, including radiology obstetrics and vascular imaging. The company leverages its expertise in digital health to develop smart ultrasound solutions that incorporate machine learning algorithms for automated assistance. Siemens Healthineers strengthens its market position by expanding its global service network and providing comprehensive training programs for sonographers. Recent actions, include the introduction of new probe technologies that offer superior penetration and resolution for difficult to scan patients. The company also focuses on sustainability by designing energy efficient systems and promoting circular economy practices in manufacturing. Siemens Healthineers collaborates with academic institutions to advance clinical research and validate new applications.

Top Strategies Used by Key Market Participants

Key players in the ultrasound devices market employ several strategic approaches to maintain competitiveness and drive growth. Product innovation is a primary strategy where companies invest in developing artificial intelligence powered features and portable handheld devices to enhance diagnostic accuracy and accessibility. Strategic partnerships with healthcare providers and technology firms allow firms to co-develop customized solutions that integrate seamlessly with existing hospital information systems. Geographic expansion is another critical approach enabling companies to establish production facilities and distribution networks in emerging markets to serve local demand efficiently. Additionally, companies focus on sustainability initiatives by designing energy efficient systems and promoting recycling programs to align with environmental regulations. Investment in research and development for advanced transducer materials and beamforming technologies helps differentiate products and improve image quality. These strategies collectively help market participants adapt to changing consumer preferences and regulatory requirements, while delivering value to customers.

RECENT MARKET HAPPENINGS

• In November 2022, ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd. submitted Premarket Approval for the Paradise uRDN system to the FDA. This system uses the catheter to be placed in the main renal arteries, which delivers a seven-second ultrasound for lowering blood pressure.
• In November 2022, Royal Philips launched a next-generation compact portable ultrasound solution, the Philips Compact 5000 series, to improve patient outcomes with high-end cart-based ultrasound systems without compromising image quality.
• In November 2022, at the 108th Scientific Assembly of the Radiological Society of North America, Samsung Electronics will introduce the latest artificial intelligence technologies in ultrasound, digital radiography, and mobile computed tomography, improving customer experience to very high levels of satisfaction.
• In November 2022, Advanced Veterinary Ultrasound and Draminski S.A. partnered to introduce better, excellent, rich, and developed systems to market features such as the Draminski Blue, iScan2, and iScan Mini systems.

SEGMENTAL ANALYSIS

The global market for ultrasound devices market has been segmented and sub-segmented based on technology, device display, portability, application and region.

By Technology

• Diagnostic Ultrasound
  • 2D Ultrasound
  • 3D & 4D Ultrasound
  • Doppler Ultrasound
• Therapeutic Ultrasound
  • High-intensity Focused Ultrasound
  • Extracorporeal Shockwave Lithotripsy

By Device Display

• Color
• Black and White

By Portability

• Trolley/Cart-based
• Compact/Handheld

By Application

• Radiology/General Imaging
• Cardiology
• Obstetrics/Gynecology
• Vascular
• Urology
• Other Applications
  • Breast Imaging
  • Hepatology
  • Anesthesiology
  • Emergency Care

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa